Rapamycin Does Not Impede Survival or Induction of Antibody Responses to Primary and Heterosubtypic Influenza Infections in Mice

Impairment of immune defenses can contribute to severe influenza infections. Rapamycin is an immunosuppressive drug often used to prevent transplant rejection and is currently undergoing clinical trials for treating cancers and autoimmune diseases. We investigated whether rapamycin has deleterious e...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Viral Immunol
Autors principals: Liepkalns, Justine S., Pandey, Aseem, Hofstetter, Amelia R., Kumar, Amrita, Jones, Enitra N., Cao, Weiping, Liu, Feng, Levine, Min Z., Sambhara, Suryaprakash, Gangappa, Shivaprakash
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5749914/
https://ncbi.nlm.nih.gov/pubmed/27447349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/vim.2016.0056
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars